L-cysteine in pet food: what changes in 2026 for manufacturers and distributors

Key data

If you manufacture, distribute or import feed for cats or dogs in the EU, this regulation affects you directly. The Implementing Regulation (EU) 2026/2129, published on 25 September 2026, renews the authorization of L-cysteine monohydrate hydrochloride as an additive in feed for companion animals, but does so under new conditions that entirely replace the previous 2015 regulatory framework.

This is not an automatic extension: the renewal involves updated conditions of use that may differ from those currently in force. Any product containing this additive outside the new authorized parameters will be exposed to market withdrawal.

What does this regulation establish?

Implementing Regulation (EU) 2026/2129 establishes the formal renewal of the authorization of L-cysteine monohydrate hydrochloride as an additive for feed intended specifically for cats and dogs. At the same time, it repeals and replaces the previous Implementing Regulation (EU) 2015/2306, which was the legal framework in force until now.

L-cysteine is an amino acid used in animal nutrition to improve the nutritional quality of feed. Its use as an additive is regulated at European level and requires express authorization for each animal species. The renewal is not automatic: it involves a re-evaluation of the conditions of use, which may result in changes in dosage, presentation forms or labeling requirements.

Companies in the sector have a transitional period to adapt their labeling and formulations, although the exact duration of this period is not specified in the published text and should be consulted in the complete articles of the regulation.

Economic and operational impact

The main impact is not a new fee or direct penalty, but the operational cost of adaptation: review of formulations, updating of labeling and, where applicable, reformulation of products that do not comply with the new authorized parameters.

• Reformulation cost: If the new conditions of use differ from current ones, manufacturers will need to adjust their recipes and submit the changes to internal quality control.
• Labeling cost: Any change in the conditions of the additive may require updating the labeling of products, with the consequent redesign and reprinting of packaging.
• Risk of market withdrawal: Products containing L-cysteine monohydrate hydrochloride outside the parameters of the new regulation may be withdrawn from the market by the competent authorities. This is the highest economic risk for companies that do not act quickly.
• Impact on the supply chain: Distributors and importers must also verify that the products they market comply with the new regulation, as responsibility does not rest exclusively with the manufacturer.

Who does it affect?

• Manufacturers of pet food and feed (cats and dogs) that use L-cysteine monohydrate hydrochloride in their formulations.
• Distributors of companion animal feed that market products with this additive in the European market.
• Importers of pet feed from third countries containing this additive and intended for the EU market.
• Quality and regulatory managers of pet food companies that manage regulatory compliance of authorized additives.
• Advisors and consultants providing services to companies in the animal feed sector.

Practical example

A Spanish company manufacturing wet cat food that uses L-cysteine monohydrate hydrochloride as an additive in several of its products should act as follows:

1. Locate in its product technical sheet the reference to Regulation (EU) 2015/2306 as the legal basis for the additive. That reference is repealed and must be updated to Regulation (EU) 2026/2129.
2. Compare the conditions of use of the new regulation with those currently applied: dosage, presentation form, restrictions. If there are differences, it must adjust the formulation.
3. Update the labeling of all affected products to reflect the new authorized conditions before the transitional period expires.
4. Communicate the changes to its distributors so they can manage existing stock with old labeling within the permitted timeframe.

If the company does not act and an inspector from the competent authority detects that the product cites a repealed regulation or applies conditions of use that are no longer in force, the product may be withdrawn from the market, with the economic and reputational cost that this entails.

What should companies do now?

1. Identify affected products: Review the complete catalog and locate all feed for cats and dogs containing L-cysteine monohydrate hydrochloride as an additive.
2. Read the complete articles of Regulation (EU) 2026/2129: Verify the new conditions of use (dosage, restrictions, presentation form) and compare them with those applied under the repealed Regulation (EU) 2015/2306.
3. Assess whether reformulation is required: If the new conditions differ from current ones, initiate the process of formulation adjustment and internal validation.
4. Update labeling: Replace the regulatory reference in the labeling of affected products and adapt any information related to the additive.
5. Inform distributors and importers: Communicate the changes in the supply chain so they can correctly manage stock with previous labeling within the transitional period.
6. Document compliance: Keep a record of the actions taken to demonstrate adaptation in case of possible inspections by the competent authorities.

Official source

Consult complete regulation in official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602129